A Quantitative ABCD Analysis of Factors Driving Share Price Volatility in the Indian Pharmaceutical Sector

Abstract

Purpose: This research employs an innovative ABCD (Advantages, Benefits, Constraints, and Disadvantages) analysis framework to intricately explore and evaluate the diverse factors influencing share price volatility in the Indian Pharmaceutical Sector. Delving into both individual and systemic characteristics, the study quantitatively assesses the effectiveness of various elements impacting share prices. Each component related to share price movements is meticulously assigned a score or weightage, providing a nuanced understanding of their respective contributions.

Design: The researcher utilized focused group interviews to collect participants’ viewpoints on the factors influencing share price dynamics in the Indian pharmaceutical industry. Opinions were obtained through designated measurements, and the collected data underwent subsequent quantitative analysis.

Findings: In the specific context of the present study, which focuses on the quantitative ABCD analysis of factors driving share price fluctuations in the Indian pharma industry, the research findings underscore the notable impact of advantageous factors on volatility. The outcome of the ABCD analysis substantiates the effectiveness of the concepts/ideas related to Factors Driving Share Price Volatility in the Indian Pharmaceutical Sector.

Originality: This research introduces a novel application of the ABCD analytical paradigm to investigate factors influencing variations in the pricing dynamics of shares in the Indian pharmaceutical industry. While ABCD analysis is prevalent in diverse areas, this study pioneers a unique exploration within the pharmaceutical domain. By identifying and evaluating the crucial elements influencing share prices, this work contributes to the originality of studies in the field, presenting a distinctive approach to understanding the dynamics of the Indian pharmaceutical market.

Type of Paper: Empirical Analysis.